SCHEMBL27934603

SCHEMBL27934603

O=CC1Oc2ccc([N+](=O)[O-])cc2N1CCCCl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CHRM2 P08172 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ DRD1 P21728 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ TSHR P16473 1/20 0.34
▸ CHRNB4 P30926 5/20 0.33
▸ CHRNA3 P32297 5/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ SIRT2 Q8IXJ6 1/20 0.33
▸ SIRT1 Q96EB6 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27934675 0.91 ALDH1A1 (0.38) L3MBTL1ALDH1A1CHRNB4CHRNA3MEN1
SCHEMBL27608978 0.80 TSHR (0.36) L3MBTL1ALDH1A1TSHRMEN1KMT2A
SCHEMBL27590541 0.80 NISCH (0.32) DRD3MAPT
SCHEMBL27590506 0.78 NPC1 (0.32) TSHRSIRT1LMNASMN1; SMN2HTT
SCHEMBL27590556 0.77 NISCH (0.36) DRD3ALDH1A1FFAR4MAPT
SCHEMBL27608930 0.74 NPC1 (0.32) SIRT1LMNASMN1; SMN2
SCHEMBL27590551 0.74 GRIA1 (0.31) HTR1A
SCHEMBL27590539 0.73 GSK3B (0.33) HTR1AALDH1A1HTT
SCHEMBL27609187 0.73 CREBBP (0.34) —
SCHEMBL27608922 0.69 NPC1 (0.33) TSHRSIRT1LMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101535276-B 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC 2013-08-28 — — CN disclosed
Send feedback